Labcorp Holdings Inc. (LH) EV/FCF Ratio: 20.47x
Is Labcorp Holdings Inc.’s EV/FCF ratio high or low?
Labcorp Holdings Inc.'s EV/FCF ratio of 20.47x is in line with its 5-year average of 20.39x, around the middle of its 5-year range (9.35x–39.01x).
As of Sunday, June 14, 2026. 8.50% below its 12-month average of 22.37x.
LH EV/FCF Ratio Chart
LH Average EV/FCF Ratio Chart
LH Current vs Average EV/FCF Ratio Chart
LH EV/FCF Ratio Metrics
EV/FCF RATIO
20.47x
EV/FCF RATIO AVG TTM
22.37x
EV/FCF RATIO AVG 3Y
25.41x
EV/FCF RATIO AVG 5Y
20.39x
EV/FCF RATIO AVG 10Y
20.22x
EV/FCF RATIO AVG 15Y
19.89x
EV/FCF RATIO AVG 20Y
18.42x
CURRENT VS TTM AVG
-8.50%
CURRENT VS 3Y AVG
-19.44%
CURRENT VS 5Y AVG
+0.41%
CURRENT VS 10Y AVG
+1.25%
CURRENT VS 15Y AVG
+2.89%
CURRENT VS 20Y AVG
+11.11%
LH Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 20.47x | 22.37x | 25.41x | 20.39x |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 31.65x | 33.78x | 33.51x | 38.36x |
| BioNTech SE (BNTX) | $22.90B | 7.86x | 21.62x | 6.22x | 11.26x |
| United Therapeutics Corporation (UTHR) | $23.17B | 24.28x | 18.78x | 16.95x | 16.99x |
| Waters Corporation (WAT) | $23.17B | 129.97x | 44.12x | 43.27x | 41.59x |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 26.90x | 26.23x | 26.23x |
| Veeva Systems Inc. (VEEV) | $25.92B | 15.02x | 28.59x | 32.68x | 38.09x |
| Hologic, Inc. (HOLX) | $16.97B | 17.53x | 16.94x | 18.67x | 15.16x |
| DexCom, Inc. (DXCM) | $29.08B | 20.94x | 37.12x | 66.70x | 181.36x |
| Biogen Inc. (BIIB) | $29.53B | 12.53x | 12.73x | 21.62x | 21.16x |
Cash Flow Valuation Comparison
EV/FCF
20.5x
P/FCF
15.9x
FCF Yield
6.27%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Labcorp Holdings Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The EV/FCF ratio for LH stock is 20.47x.
- Is Labcorp Holdings Inc.'s EV/FCF ratio high or low?
- Labcorp Holdings Inc.'s EV/FCF ratio of 20.47x is in line with its 5-year average of 20.39x, around the middle of its 5-year range (9.35x–39.01x).
- What is the TTM average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The TTM average EV/FCF ratio for LH stock is 22.37x.
- What is the 3Y average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The 3Y average EV/FCF ratio for LH stock is 25.41x.
- What is the 5Y average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The 5Y average EV/FCF ratio for LH stock is 20.39x.
- What is the 10Y average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The 10Y average EV/FCF ratio for LH stock is 20.22x.
- What is the 15Y average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The 15Y average EV/FCF ratio for LH stock is 19.89x.
- What is the 20Y average EV/FCF ratio for Labcorp Holdings Inc. (LH)?
- The 20Y average EV/FCF ratio for LH stock is 18.42x.
Labcorp Holdings Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-12 | 20.47x |
| 2026-06-11 | 20.41x |
| 2026-06-10 | 20.61x |
| 2026-06-09 | 20.77x |
| 2026-06-08 | 20.22x |
| 2026-06-05 | 20.40x |
| 2026-06-04 | 20.15x |
| 2026-06-03 | 20.03x |
| 2026-06-02 | 19.96x |
| 2026-06-01 | 19.91x |
| 2026-05-29 | 20.10x |
| 2026-05-28 | 20.26x |
| 2026-05-27 | 19.99x |
| 2026-05-26 | 20.00x |
| 2026-05-22 | 20.09x |
| 2026-05-21 | 19.84x |
| 2026-05-20 | 19.94x |
| 2026-05-19 | 19.72x |
| 2026-05-18 | 19.83x |
| 2026-05-15 | 19.52x |
| 2026-05-14 | 19.74x |
| 2026-05-13 | 19.76x |
| 2026-05-12 | 19.94x |
| 2026-05-11 | 19.80x |
| 2026-05-08 | 19.74x |
| 2026-05-07 | 19.98x |
| 2026-05-06 | 19.91x |
| 2026-05-05 | 19.93x |
| 2026-05-04 | 19.68x |
| 2026-05-01 | 23.19x |
| 2026-04-30 | 23.25x |
| 2026-04-29 | 23.28x |
| 2026-04-28 | 23.44x |
| 2026-04-27 | 23.71x |
| 2026-04-24 | 23.74x |
| 2026-04-23 | 23.81x |
| 2026-04-22 | 24.34x |
| 2026-04-21 | 24.40x |
| 2026-04-20 | 24.11x |
| 2026-04-17 | 24.21x |
| 2026-04-16 | 23.91x |
| 2026-04-15 | 23.94x |
| 2026-04-14 | 24.08x |
| 2026-04-13 | 23.76x |
| 2026-04-10 | 23.54x |
| 2026-04-09 | 24.39x |
| 2026-04-08 | 24.49x |
| 2026-04-07 | 24.11x |
| 2026-04-06 | 24.47x |
| 2026-04-02 | 24.42x |
| 2026-04-01 | 24.35x |
| 2026-03-31 | 23.94x |
| 2026-03-30 | 23.72x |
| 2026-03-27 | 23.76x |
| 2026-03-26 | 24.05x |
| 2026-03-25 | 23.89x |
| 2026-03-24 | 23.90x |
| 2026-03-23 | 23.78x |
| 2026-03-20 | 23.68x |
| 2026-03-19 | 23.76x |
| 2026-03-18 | 23.88x |
| 2026-03-17 | 24.21x |
| 2026-03-16 | 23.95x |
| 2026-03-13 | 23.74x |
| 2026-03-12 | 23.67x |
| 2026-03-11 | 24.19x |
| 2026-03-10 | 24.07x |
| 2026-03-09 | 24.41x |
| 2026-03-06 | 24.14x |
| 2026-03-05 | 24.57x |
| 2026-03-04 | 24.91x |
| 2026-03-03 | 25.06x |
| 2026-03-02 | 25.30x |
| 2026-02-27 | 25.48x |
| 2026-02-26 | 25.38x |
| 2026-02-25 | 25.04x |
| 2026-02-24 | 25.34x |
| 2026-02-23 | 22.09x |
| 2026-02-20 | 21.93x |
| 2026-02-19 | 21.92x |
| 2026-02-18 | 21.69x |
| 2026-02-17 | 21.57x |
| 2026-02-13 | 21.93x |
| 2026-02-12 | 21.66x |
| 2026-02-11 | 22.37x |
| 2026-02-10 | 22.04x |
| 2026-02-09 | 21.41x |
| 2026-02-06 | 21.60x |
| 2026-02-05 | 21.66x |
| 2026-02-04 | 21.54x |
| 2026-02-03 | 21.30x |
| 2026-02-02 | 21.18x |
| 2026-01-30 | 21.26x |
| 2026-01-29 | 21.15x |
| 2026-01-28 | 21.04x |
| 2026-01-27 | 21.23x |
| 2026-01-26 | 21.00x |
| 2026-01-23 | 20.96x |
| 2026-01-22 | 21.16x |
| 2026-01-21 | 21.11x |
| 2026-01-20 | 21.24x |
| 2026-01-16 | 21.22x |
| 2026-01-15 | 21.10x |
| 2026-01-14 | 20.68x |
| 2026-01-13 | 20.19x |
| 2026-01-12 | 19.97x |
| 2026-01-09 | 20.06x |
| 2026-01-08 | 20.23x |
| 2026-01-07 | 20.18x |
| 2026-01-06 | 20.58x |
| 2026-01-05 | 20.14x |
| 2026-01-02 | 20.05x |
| 2025-12-31 | 20.00x |
| 2025-12-30 | 20.14x |
| 2025-12-29 | 20.13x |
| 2025-12-26 | 20.19x |
| 2025-12-24 | 20.22x |
| 2025-12-23 | 20.14x |
| 2025-12-22 | 20.26x |
| 2025-12-19 | 20.07x |
| 2025-12-18 | 20.07x |
| 2025-12-17 | 20.30x |
| 2025-12-16 | 20.44x |
| 2025-12-15 | 20.76x |
| 2025-12-12 | 20.81x |
| 2025-12-11 | 20.84x |
| 2025-12-10 | 20.68x |
| 2025-12-09 | 20.44x |
| 2025-12-08 | 20.55x |
| 2025-12-05 | 20.46x |
| 2025-12-04 | 20.65x |
| 2025-12-03 | 20.91x |
| 2025-12-02 | 20.92x |
| 2025-12-01 | 21.03x |
| 2025-11-28 | 21.09x |
| 2025-11-26 | 21.06x |
| 2025-11-25 | 21.15x |
| 2025-11-24 | 20.88x |
| 2025-11-21 | 20.90x |
| 2025-11-20 | 20.65x |
| 2025-11-19 | 20.59x |
| 2025-11-18 | 20.55x |
| 2025-11-17 | 20.64x |
| 2025-11-14 | 20.98x |
| 2025-11-13 | 21.03x |
| 2025-11-12 | 20.92x |
| 2025-11-11 | 21.06x |
| 2025-11-10 | 20.63x |
| 2025-11-07 | 20.12x |
| 2025-11-06 | 19.75x |
| 2025-11-05 | 19.99x |
| 2025-11-04 | 20.09x |
| 2025-11-03 | 20.43x |
| 2025-10-31 | 20.19x |
| 2025-10-30 | 21.49x |
| 2025-10-29 | 21.21x |
| 2025-10-28 | 21.98x |
| 2025-10-27 | 23.05x |
| 2025-10-24 | 23.30x |
| 2025-10-23 | 23.60x |
| 2025-10-22 | 23.53x |
| 2025-10-21 | 23.61x |
| 2025-10-20 | 24.07x |
| 2025-10-17 | 23.73x |
| 2025-10-16 | 23.58x |
| 2025-10-15 | 23.52x |
| 2025-10-14 | 23.32x |
| 2025-10-13 | 23.11x |
| 2025-10-10 | 23.20x |
| 2025-10-09 | 23.19x |
| 2025-10-08 | 23.17x |
| 2025-10-07 | 23.31x |
| 2025-10-06 | 23.01x |
| 2025-10-03 | 23.13x |
| 2025-10-02 | 23.30x |
| 2025-10-01 | 23.27x |
| 2025-09-30 | 23.81x |
| 2025-09-29 | 23.52x |
| 2025-09-26 | 23.38x |
| 2025-09-25 | 23.08x |
| 2025-09-24 | 23.29x |
| 2025-09-23 | 23.33x |
| 2025-09-22 | 23.26x |
| 2025-09-19 | 23.16x |
| 2025-09-18 | 23.15x |
| 2025-09-17 | 23.08x |
| 2025-09-16 | 22.94x |
| 2025-09-15 | 23.03x |
| 2025-09-12 | 23.20x |
| 2025-09-11 | 23.32x |
| 2025-09-10 | 22.87x |
| 2025-09-09 | 23.21x |
| 2025-09-08 | 23.15x |
| 2025-09-05 | 23.25x |
| 2025-09-04 | 23.02x |
| 2025-09-03 | 22.93x |
| 2025-09-02 | 22.92x |
| 2025-08-29 | 23.20x |
| 2025-08-28 | 23.02x |
| 2025-08-27 | 23.29x |
| 2025-08-26 | 23.23x |
| 2025-08-25 | 23.08x |
| 2025-08-22 | 23.22x |
| 2025-08-21 | 23.11x |
| 2025-08-20 | 23.21x |
| 2025-08-19 | 23.06x |
| 2025-08-18 | 22.70x |
| 2025-08-15 | 22.70x |
| 2025-08-14 | 22.75x |
| 2025-08-13 | 22.84x |
| 2025-08-12 | 22.62x |
| 2025-08-11 | 22.52x |
| 2025-08-08 | 22.39x |
| 2025-08-07 | 22.00x |
| 2025-08-06 | 22.06x |
| 2025-08-05 | 22.24x |
| 2025-08-04 | 22.26x |
| 2025-08-01 | 22.10x |
| 2025-07-31 | 24.37x |
| 2025-07-30 | 24.65x |
| 2025-07-29 | 24.49x |
| 2025-07-28 | 24.50x |
| 2025-07-25 | 24.73x |
| 2025-07-24 | 24.93x |
| 2025-07-23 | 23.67x |
| 2025-07-22 | 23.78x |
| 2025-07-21 | 23.12x |
| 2025-07-18 | 23.17x |
| 2025-07-17 | 23.43x |
| 2025-07-16 | 23.34x |
| 2025-07-15 | 23.31x |
| 2025-07-14 | 23.62x |
| 2025-07-11 | 23.61x |
| 2025-07-10 | 23.90x |
| 2025-07-09 | 24.30x |
| 2025-07-08 | 24.18x |
| 2025-07-07 | 24.21x |
| 2025-07-03 | 24.50x |
| 2025-07-02 | 24.36x |
| 2025-07-01 | 24.68x |
| 2025-06-30 | 24.55x |
| 2025-06-27 | 24.41x |
| 2025-06-26 | 24.14x |
| 2025-06-25 | 24.27x |
| 2025-06-24 | 24.55x |
| 2025-06-23 | 24.44x |
| 2025-06-20 | 24.50x |
| 2025-06-18 | 24.47x |
| 2025-06-17 | 24.32x |
| 2025-06-16 | 24.65x |
| 2025-06-13 | 24.45x |
| 2025-06-12 | 24.49x |
| 2025-06-11 | 24.36x |
| 2025-06-10 | 24.32x |
| 2025-06-09 | 24.05x |
| 2025-06-06 | 23.92x |
| 2025-06-05 | 23.79x |
| 2025-06-04 | 23.95x |
| 2025-06-03 | 23.67x |
| 2025-06-02 | 23.48x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter